The RDoC framework: facilitating transition from ICD/DSM to dimensional approaches that integrate neuroscience and psychopathology

In 2008, the National Institute of Mental Health (NIMH) included in its new Strategic Plan the following aim: “Develop, for research purposes, new ways of classifying mental disorders based on dimensions of observable behavior and neurobiological measures”. The implementation of this aim was named the Research Domain Criteria project, or RDoC. RDoC is a programmatic initiative that will fund grants, contracts, early‐phase trials, and similar activities for the purpose of generating studies to build a research literature that can inform future versions of psychiatric nosologies based upon neuroscience and behavioral science rather than descriptive phenomenology. RDoC departs markedly from the DSM and ICD processes, in which extensive workgroup meetings generate final and finely‐honed sets of diagnoses that are modified in field tests only if problems with clinical utility arise. Rather, in keeping with its provenance as an experimental system, the RDoC provides a framework for conducting research in terms of fundamental circuit‐based behavioral dimensions that cut across traditional diagnostic categories. While an important aim of the project is to validate particular dimensions as useful for eventual clinical work, an equally important goal is to provide information and experience about how to conceive and implement such an alternative approach to future diagnostic practices that can harness genetics and neuroscience in the service of more effective treatment and prevention. This paper summarizes the rationale for the RDoC project, its essential features, and potential methods of transitioning from DSM/ICD categories to dimensionally‐oriented designs in research studies.

[1]  M. Egan,et al.  Schizophrenia, just the facts What do we know, how well do we know it? , 1988, Schizophrenia Research.

[2]  M. Egan,et al.  Catechol O-methyltransferase val158-met genotype and individual variation in the brain response to amphetamine , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[3]  M. Zimmerman,et al.  Prevalence of attenuated psychotic symptoms and their relationship with DSM-IV diagnoses in a general psychiatric outpatient clinic. , 2013, The Journal of clinical psychiatry.

[4]  Jennifer A. Silvers,et al.  Functional imaging studies of emotion regulation: a synthetic review and evolving model of the cognitive control of emotion , 2012, Annals of the New York Academy of Sciences.

[5]  A. Wagner,et al.  The hippocampal formation in schizophrenia. , 2010, The American journal of psychiatry.

[6]  P. Lang,et al.  THE ANXIETY SPECTRUM AND THE REFLEX PHYSIOLOGY OF DEFENSE: FROM CIRCUMSCRIBED FEAR TO BROAD DISTRESS , 2012, Depression and anxiety.

[7]  D. Zald,et al.  Reconsidering anhedonia in depression: Lessons from translational neuroscience , 2011, Neuroscience & Biobehavioral Reviews.

[8]  D. Tucker,et al.  Frontolimbic response to negative feedback in clinical depression. , 2003, Journal of abnormal psychology.

[9]  D. Bolton Should mental disorders be regarded as brain disorders? 21st century mental health sciences and implications for research and training , 2013, World psychiatry : official journal of the World Psychiatric Association.

[10]  M. Keshavan,et al.  Schizophrenia, “Just the Facts” 6. Moving ahead with the schizophrenia concept: From the elephant to the mouse , 2011, Schizophrenia Research.

[11]  T. Kotchen Historical trends and milestones in hypertension research: a model of the process of translational research. , 2011, Hypertension.

[12]  K. Berridge Food reward: Brain substrates of wanting and liking , 1996, Neuroscience & Biobehavioral Reviews.

[13]  T. Insel,et al.  Why has it taken so long for biological psychiatry to develop clinical tests and what to do about it? , 2012, Molecular Psychiatry.

[14]  Michael J. Owen,et al.  The Kraepelinian dichotomy – going, going... but still not gone , 2010, British Journal of Psychiatry.

[15]  J. Wakefield The perils of dimensionalization: challenges in distinguishing negative traits from personality disorders. , 2008, The Psychiatric clinics of North America.

[16]  M. Kozak,et al.  Developing constructs for psychopathology research: research domain criteria. , 2010, Journal of abnormal psychology.

[17]  James R. Yancey,et al.  A construct-network approach to bridging diagnostic and physiological domains: application to assessment of externalizing psychopathology. , 2013, Journal of abnormal psychology.

[18]  J. Ford,et al.  Neurophysiological studies of auditory verbal hallucinations. , 2012, Schizophrenia bulletin.

[19]  R. Krueger,et al.  Personality traits and the classification of mental disorders: toward a more complete integration in DSM-5 and an empirical model of psychopathology. , 2010, Personality disorders.

[20]  D. Barch,et al.  The Cognitive Neuroscience of Working Memory: Relevance to CNTRICS and Schizophrenia , 2008, Biological Psychiatry.

[21]  F. Kobeissy,et al.  An updated overview of animal models in neuropsychiatry , 2013, Neuroscience.

[22]  Niall (aka Jock) McLaren Cells, Circuits, and Syndromes: A Critical Commentary on the NIMH Research Domain Criteria Project , 2011, Ethical Human Psychology and Psychiatry.

[23]  James L Olds,et al.  Positive reinforcement produced by electrical stimulation of septal area and other regions of rat brain. , 1954, Journal of comparative and physiological psychology.

[24]  Jerome C Wakefield,et al.  Are you as smart as a 4th grader? Why the prototype‐similarity approach to diagnosis is a step backward for a scientific psychiatry , 2012, World psychiatry : official journal of the World Psychiatric Association.

[25]  J. Os,et al.  Psychotic symptoms in non-clinical populations and the continuum of psychosis , 2002, Schizophrenia Research.

[26]  W. Bechtel Reducing Psychology while Maintaining its Autonomy via Mechanistic Explanations , 2006 .

[27]  Cameron S Carter,et al.  Cognitive deficits in unaffected first-degree relatives of schizophrenia patients: a meta-analytic review of putative endophenotypes. , 2005, Schizophrenia bulletin.

[28]  R. Bluhm,et al.  A review of neuroimaging studies in PTSD: heterogeneity of response to symptom provocation. , 2006, Journal of psychiatric research.

[29]  Mark A. Smith,et al.  Challenges and opportunities for drug discovery in psychiatric disorders: the drug hunters' perspective. , 2010, The international journal of neuropsychopharmacology.

[30]  Michael Davis,et al.  Neural systems involved in fear and anxiety measured with fear-potentiated startle. , 2006, The American psychologist.

[31]  Gregory T. Smith,et al.  On the value of homogeneous constructs for construct validation, theory testing, and the description of psychopathology. , 2009, Psychological assessment.